Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction

Authors: Ehses, Jan; Ellingsgaard, Helga; Boni-Schnetzler, Marianne; Donath, Marc

Source: Archives of Physiology and Biochemistry, Volume 115, Number 4, October 2009 , pp. 240-247(8)

Buy & download fulltext article:

Price: $42.29 plus tax (Refund Policy)

Abstract:

Evidence in support of the concept of local pancreatic islet inflammation as a mechanism of β cell failure in type 2 diabetes is accumulating. Observations in human islets from type 2 diabetic patients and rodent models of the disease indicate the increased presence of IL-1 driven cytokines and chemokines in pancreatic islets, concomitant with immune cell infiltration. Inflammation is the body's protective response to harmful stimuli and tissue damage. However, under chronic stress (e.g. metabolic stress in obesity and type 2 diabetes) the body's own defensive response may become deleterious to tissue function. Here, we summarize the current evidence that islet inflammation is a feature of type 2 diabetes, and discuss its role with respect to α and β cell compensation and eventual β cell failure.

Document Type: Research article

DOI: http://dx.doi.org/10.1080/13813450903025879

Affiliations: 1: Division of Endocrinology, Diabetes and Nutrition and the Center for Integrated Human Physiology, University Hospital of Zurich, 8091 Zurich, Switzerland

Publication date: 2009-10-01

More about this publication?